Iovance Biotherapeutics, Inc. (IOVA): Price and Financial Metrics

Iovance Biotherapeutics, Inc. (IOVA)

Today's Latest Price: $38.50 USD

0.85 (2.26%)

Updated Oct 26 9:37am

Add IOVA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

IOVA Stock Price Chart Interactive Chart >

Price chart for IOVA

IOVA Price/Volume Stats

Current price $38.50 52-week high $41.49
Prev. close $37.65 52-week low $18.70
Day low $37.07 Volume 40,229
Day high $38.58 Avg. volume 1,767,517
50-day MA $32.62 Dividend yield N/A
200-day MA $30.50 Market Cap 5.64B

Iovance Biotherapeutics, Inc. (IOVA) Company Bio

Iovance Biotherapeutics, formerly known as Lion Biotechnologies, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company was founded in 2007 and is based in Woodland Hills, California.

IOVA Latest News Stream

Event/Time News Detail
Loading, please wait...

IOVA Latest Social Stream

Loading social stream, please wait...

View Full IOVA Social Stream

Latest IOVA News From Around the Web

Below are the latest news stories about Iovance Biotherapeutics Inc that investors may wish to consider to help them evaluate IOVA as an investment opportunity.

Iovance Biotherapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 2020

SAN CARLOS, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report its second quarter 2020 financial results on Thursday, August 6, 2020. Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30 p.m. EDT. To participate in the conference call, please dial 1-844-646-4465 (domestic) or 1-615-247-0257 (international) and reference the access code 7875997. The live webcast can be accessed in the Investors section of the Company’s website at The archived webcast will be available for one year.About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics aims to improve pati...

Yahoo | July 23, 2020

Steven Cohen Homes in on Otonomy

Guru ups bet in biotech focused on ear-related disorders Continue reading...

Yahoo | July 15, 2020

Were Hedge Funds Right About Iovance Biotherapeutics, Inc. (IOVA)?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

Yahoo | July 14, 2020

Is Iovance Biotherapeutics a Buy?

After rumors swirled about a potential acquisition, it now appears the biopharma is transitioning to commercial operations as a standalone company.

Yahoo | July 1, 2020

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Buy at $23, Sell at $47 - Live Trading News

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) $IOVA #Stocks #biopharmaceutical #MedicalStocks #Healthcarenews Buy at $23, Sell at $47 IOVA’s tumour infiltrating lymphocyte (TIL) therapy showed promising efficacy in metastatic melanoma Iovance BiotherapeuticsTicker: NASDAQ:IOVAPrice: $28.69Recommendation: Buy Sector News It is sad, but cancer is a pervasive illness that has affected 16% of the population of the world. In order […]

Live Trading News | June 25, 2020

Read More 'IOVA' Stories Here

IOVA Price Returns

1-mo 21.03%
3-mo 33.68%
6-mo 15.44%
1-year 87.71%
3-year 427.40%
5-year 476.35%
YTD 39.09%
2019 212.77%
2018 10.63%
2017 15.11%
2016 -9.97%
2015 -1.91%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8224 seconds.